Results 171 to 180 of about 331,793 (319)

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi   +6 more
wiley   +1 more source

Cerebrovascular disorders

open access: yes, 2016
Cerebrovascular disorders represent one of the most prevalent and devastating diseases of adults. One in every ten deaths worldwide is due to stroke and more than half of stroke survivors are left dependent on others for everyday activities. The epidemiology and management of cerebrovascular disorders are evolving quickly.
Feigin, V, Wiebers, DO, Bennett, D
openaire   +1 more source

Cognitive and behavioural predictors of survival in Alzheimer disease:results from a sample of treated patients in a tertiary-referral memory clinic [PDF]

open access: yes, 2012
Agüero-Torres   +59 more
core   +1 more source

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

open access: yesEuropean Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak   +15 more
wiley   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

open access: yesEpilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE). [PDF]

open access: yesJ Stroke Cerebrovasc Dis, 2020
Abootalebi S   +70 more
europepmc   +1 more source

Late‐onset epilepsy of unknown etiology is more treatment‐responsive than acquired lesional late‐onset epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Late‐onset epilepsy of unknown etiology (LOEU) carries an elevated risk of dementia, suggesting that it may represent an early manifestation of neurodegenerative or cerebrovascular disease. Direct comparisons between LOEU and acquired lesional late‐onset epilepsy (LOE) may elucidate clinical features specific to LOEU.
L. Brian Hickman   +9 more
wiley   +1 more source

Defining the role of systemic autoimmune markers in adult epilepsy: A focus on autoimmune‐associated epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Objective Autoimmune mechanisms are a recognized cause of adult epilepsy, with immunotherapy offering etiology‐specific treatment. Autoimmune‐associated epilepsy is an emerging clinical entity, for which early diagnosis remains challenging and largely depends on neuronal antibody testing.
I‐Ting Lin   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy